Phase II and pharmacogenomics study of enzastaurin plus temozolomide during and following radiation therapy in patients with newly diagnosed glioblastoma multiforme and gliosarcoma

類似資料

• Enzastaurin plus temozolomide with radiation therapy in glioblastoma multiforme: A phase I study(†)
  著者:: Butowski, Nicholas, 等
  出版事項: (2010)
• Phase II Study of Erlotinib Plus Temozolomide During and After Radiation Therapy in Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma
  著者:: Prados, Michael D., 等
  出版事項: (2009)
• Therapeutic management of gliosarcoma in the temozolomide era
  著者:: McAleer, Mary Frances, 等
  出版事項: (2015)
• Six-month progression-free survival as an alternative primary efficacy endpoint to overall survival in newly diagnosed glioblastoma patients receiving temozolomide
  著者:: Polley, Mei-Yin C., 等
  出版事項: (2010)
• Quality of life in low-grade glioma patients receiving temozolomide
  著者:: Liu, Raymond, 等
  出版事項: (2009)